Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Kinesin-like protein KIF1A is a neuron-specific, microtubule-based motor protein encoded by the KIF1A gene in humans[1]. It belongs to the kinesin-3 subfamily and primarily mediates long-distance anterograde axonal transport of membranous cargoes, including synaptic vesicle precursors and dense core vesicles, by hydrolyzing ATP to generate mechanical force and “walk” along microtubules[1][3]. KIF1A is essential for neuronal survival, synaptic transmission, brain development, and higher cognitive function[1]. Disruption or mutation of KIF1A leads to severe neurodevelopmental and neurodegenerative disorders, collectively known as KIF1A-associated neurological disorders (KAND), characterized by spasticity, intellectual disability, and peripheral neuropathy[2][4][5]. Mechanistically, KIF1A is distinguished by high processivity and rapid movement powered by structural features such as its motor domain and the lysine-rich K-loop, allowing efficient delivery of cargo throughout the neuron[3][5]. While KIF1A is a recognized therapeutic target due to its role in neuronal health and disease, clinically relevant modulators have not yet been described in the literature[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinesin-like protein KIF1A (KIF1A).